An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC
Clinical trial NCT05252091 · UNKNOWN
Trial details
- NCT number
- NCT05252091
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-20
- Primary completion
- 2022-08-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.